News | Magnetic Resonance Imaging (MRI) | April 24, 2017

Toshiba Showcases Vantage Galan 3T MRI at ISMRM 2017

Premium system delivers fast, accurate results in routine and advanced imaging

Toshiba Showcases Vantage Galan 3T MRI at ISMRM 2017

April 24, 2017 — Offering a full range of advanced clinical applications for researchers, Toshiba Medical will demonstrate the Vantage Galan 3T, at the 2017 International Society for Magnetic Resonance in Medicine (ISMRM) annual meeting, April 22-27 in Honolulu, Hawaii.

With advanced applications that include neuro, musculoskeletal (MSK), abdominal, cardiovascular, breast and prostate, the Vantage Galan 3T is designed to increase signal-to-noise ratio (SNR) by up to 20 percent, allowing for faster sampling and higher resolution images thanks to PURERF and Saturn technologies. This combined with the ability to stack protocol sequences results in quick neuro exams. The system enhances diagnostic confidence with new advanced clinical applications and helps make exams easy to perform with EasyTech workflow solutions, which streamline positioning and scanning. Additionally, the system offers non-contrast magnetic resonance angiography (MRA) sequences and makes scanning even more quiet with Pianissimo Zen technology that reduces sound during acquisition by 99 percent.

Toshiba Medical will also sponsor a Lunch Symposium with lectures on diffusion MRI and advanced MSK techniques at 3T.

For more information: www.medical.toshiba.com

Related Content

Videos | Computed Tomography (CT) | July 19, 2019
Quynh Truong, M.D., MPH, associate professor of radio
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Mednax National Cardiac Centers of Excellence Program Highlighted at SCCT 2019
News | CT Angiography (CTA) | July 11, 2019
Mednax Inc. and Mednax Radiology Solutions announced that Chief Medical Officer Ricardo C. Cury, M.D., FSCCT, will...
360 Photos | Ultrasound Imaging | July 11, 2019
This 360 degree photo shows a basic, point-of-care cardiac echocardiogram being performed using a smartphone turned i
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Achenbach to Receive Inaugural 2019 Stephan Achenbach Pioneer Award in Cardiovascular CT
News | Cardiac Imaging | July 10, 2019
The Society of Cardiovascular Computed Tomography (SCCT) will present Stephan Achenbach, M.D., FSCCT with the inaugural...
360 Photos | Ultrasound Imaging | July 09, 2019
A view of a mitral valve on a GE Healthcare Vivid E95 ...